Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


03.10.2017

1 Arch Virol
2 BMC Cancer
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
2 Gastroenterol Hepatol
1 Gastroenterology
1 Gut
8 Hepatology
4 J Hepatol
1 J Immunol
2 J Med Virol
1 J Virol
1 Lancet
1 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
2 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. RAMIREZ-SOTO MC, Bracho MA, Gonzalez-Candelas F, Huichi-Atamari M, et al
    Genotypes and subgenotypes of hepatitis B virus circulating in an endemic area in Peru.
    Arch Virol. 2017 Sep 25. doi: 10.1007/s00705-017-3557.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. ZHANG QB, Jia QA, Wang H, Hu CX, et al
    High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    BMC Cancer. 2016;16:880.
    PubMed     Text format     Abstract available

  3. QUE J, Kuo HT, Lin LC, Lin KL, et al
    Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
    BMC Cancer. 2016;16:451.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  4. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  5. HUANG R, Wang J, Zhao XA, Xia J, et al
    The impact of cirrhosis on the efficacy and safety of entecavir for patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017;29:1314.
    PubMed     Text format    

  6. MOHAMED MS, Hanafy AS, Bassiony MAA, Hussein S, et al
    Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients.
    Eur J Gastroenterol Hepatol. 2017 Sep 25. doi: 10.1097/MEG.0000000000000963.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  7. SENOSIAIN C, Gonzalez-Tallon A A, Lopez-Sanroman A, Mateos ML, et al
    Hepatitis E seroprevalence in inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Aug 6. pii: S0210-5705(15)00148.
    PubMed     Text format     Abstract available

  8. LLOVET LP, Rodriguez-Tajes S, Londono MC
    [Treatment of hepatitis C before and after liver transplantation].
    Gastroenterol Hepatol. 2015 Nov 4. pii: S0210-5705(15)00225.
    PubMed     Text format     Abstract available


    Gastroenterology

  9. MONTPELLIER C, Wychowski C, Sayed IM, Meunier JC, et al
    Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
    Gastroenterology. 2017 Sep 25. pii: S0016-5085(17)36179.
    PubMed     Text format     Abstract available


    Gut

  10. PFEFFERKORN M, Bohm S, Schott T, Deichsel D, et al
    Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers.
    Gut. 2017 Sep 26. pii: gutjnl-2017-313811. doi: 10.1136/gutjnl-2017-313811.
    PubMed     Text format     Abstract available


    Hepatology

  11. PHILIPS CA, Augustine P
    Plasma biomarkers to diagnose alcoholic hepatitis - are we there yet?
    Hepatology. 2017 Sep 23. doi: 10.1002/hep.29547.
    PubMed     Text format    

  12. YARTEL AK, Rein DB, Ann Brown K, Krauskopf K, et al
    Hepatitis C Virus Testing for Case Identification in Persons Born during 1945-1965: Results from Three Randomized Controlled Trials.
    Hepatology. 2017 Sep 23. doi: 10.1002/hep.29548.
    PubMed     Text format     Abstract available

  13. MAURO E, Crespo G, Montironi C, Londono MC, et al
    Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after SVR in recurrent hepatitis C.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29557.
    PubMed     Text format     Abstract available

  14. MAUGE L, Pavie J, Batisse D, Darnige L, et al
    Acquired hemophilia A resolution in an HCV/HIV coinfected patient with cure of hepatitis C by direct antiviral agents.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29560.
    PubMed     Text format    

  15. AHMED A, Beckerman R, Younossi ZM
    Equitable Access to All-Oral Direct-Acting Antiviral Therapy is a Mandatory Step to Achieve Global Hepatitis C Virus Eradication.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29555.
    PubMed     Text format    

  16. CHTIOUI H
    OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29556.
    PubMed     Text format    

  17. NIMGAONKAR I, Ploss A
    A porcine model for chronic hepatitis E.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29566.
    PubMed     Text format    

  18. KAMILI S, Drobeniuc J, Mixson-Hayden T, Kodani M, et al
    Delta Hepatitis: Towards Improved Diagnostics.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29564.
    PubMed     Text format    


    J Hepatol

  19. ESMAT G, Elbaz T, El Raziky M, Gomaa A, et al
    Effectiveness of ravidasvir plus sofosbuvir in interferon-naive and treated patients with chronic hepatitis c genotype-4.
    J Hepatol. 2017 Sep 18. pii: S0168-8278(17)32286.
    PubMed     Text format     Abstract available

  20. LIU X, Shen JJ, Jung Kim S, Lee YJ, et al
    Necessity of time series analysis and effects of direct-acting antivirals on HCV patients awaiting liver transplantation.
    J Hepatol. 2017 Sep 19. pii: S0168-8278(17)32290.
    PubMed     Text format    

  21. DI MAIO VC, Cento V, Aragri M, Paolucci S, et al
    Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: what are the chances for second-line regimens?
    J Hepatol. 2017 Sep 20. pii: S0168-8278(17)32288.
    PubMed     Text format    

  22. CARRIERI MP, Protopopescu C, Marcellin F, Rosellini S, et al
    Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.
    J Hepatol. 2017 Sep 12. pii: S0168-8278(17)32211.
    PubMed     Text format     Abstract available


    J Immunol

  23. RESHEQ YJ, Menzner AK, Bosch J, Tickle J, et al
    Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13.
    J Immunol. 2017;199:1672-1681.
    PubMed     Text format     Abstract available


    J Med Virol

  24. RAHMAN M, Hossain ME, Afrad MH, Hasan R, et al
    Hepatitis C Virus infections among clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2017 Sep 28. doi: 10.1002/jmv.24955.
    PubMed     Text format     Abstract available

  25. CIANCIO A, Bosio R, Bo S, Pellegrini M, et al
    SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.
    J Med Virol. 2017 Sep 28. doi: 10.1002/jmv.24954.
    PubMed     Text format     Abstract available


    J Virol

  26. QIN Y, Xue B, Liu C, Wang X, et al
    NLRX1 mediates MAVS degradation to attenuate hepatitis C virus-induced innate immune response through PCBP2.
    J Virol. 2017 Sep 27. pii: JVI.01264-17. doi: 10.1128/JVI.01264.
    PubMed     Text format     Abstract available


    Lancet

  27. GARCIA-TARDON N, Gresnigt TM, Fofanah AB, Grobusch MP, et al
    Hepatitis B and C in Tonkolili Province, Sierra Leone.
    Lancet. 2017;390:1485.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  28. FLANIGAN CA, Leung SJ, Rowe KA, Levey WK, et al
    Evaluation of the Impact of Mandating Health Care Providers to Offer Hepatitis C Virus Screening to All Persons Born During 1945-1965 - New York, 2014.
    MMWR Morb Mortal Wkly Rep. 2017;66:1023-1026.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  29. SERRANTI D, Indolfi G, Nebbia G, Cananzi M, et al
    Transient Hypothyroidism and Autoimmune Thyroiditis in Children with Chronic Hepatitis C Treated with Pegylated-Interferon-alpha-2b and Ribavirin.
    Pediatr Infect Dis J. 2017 Sep 22. doi: 10.1097/INF.0000000000001791.
    PubMed     Text format     Abstract available


    PLoS One

  30. WANG H, Zhang W, Gu H, Chen W, et al
    Identification and characterization of two linear epitope motifs in hepatitis E virus ORF2 protein.
    PLoS One. 2017;12:e0184947.
    PubMed     Text format     Abstract available

  31. HOU J, Brouwer WP, Kreefft K, Gama L, et al
    Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection.
    PLoS One. 2017;12:e0179920.
    PubMed     Text format     Abstract available


    Vaccine

  32. WANG J, Qiu J, Zhu Y, Zhou H, et al
    Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Vaccine. 2017;35:5808-5813.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: